Suchergebnisse - "RNA, Viral"

PubPharm (1.844)

1

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

enthalten in: The Journal of infectious diseases | 2023

von Scévola, S. | Niubó, J. | Domingo, P. | +10

2

Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries

enthalten in: AIDS (London, England) | 2023

von De Castro, N. | Chazallon, C. | Brites, C. | +11

3

Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Saborido-Alconchel, A. | Serna-Gallego, A. | Lopez-Cortes, L. | +11

ErratumIn: J Antimicrob Chemother. 2023 Nov 03;:. - PMID 37935622

4

Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon : Findings during the COVID-19 pandemic

enthalten in: HIV medicine | 2023

von Ka'e, A. | Fokam, J. | Togna Pabo, W. | +20

5

Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection : 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Overton, E. | Richmond, G. | Rizzardini, G. | +22

CommentIn: Clin Infect Dis. 2023 May 3;76(9):1655-1657. - PMID 36660823

6

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1) : Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Llibre, J. | Brites, C. | Cheng, C. | +14

CommentIn: Int J Antimicrob Agents. 2023 Aug;62(2):106839. - PMID 37160239

7

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV : Week 24 Results From IMPAACT 2014

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Melvin, A. | Yee, K. | Gray, K. | +19

8

Dolutegravir Plus Lamivudine Dual-Drug Regimen in Treatment-Naive HIV-1-Infected Patients With High-Level Viral Load : Preliminary Data From the Real World

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Zhao, F. | Rao, M. | Chen, W. | +7

9

Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Schürmann, D. | Jackson Rudd, D. | Schaeffer, A. | +13

10

Dolutegravir Plus Lamivudine as Initial Therapy for HIV-1 Infected and ARV-naïve Patients in West China, 24-Weeks Results of a Preliminary Real-world Study

enthalten in: Current HIV research | 2022

von Hui, X. | Gan, X. | Li, Q. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[185]